Narnolia

Narnolia

Toll Free No: 1800-103-7212

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE427.7013.2 (+3.18 %)
PREV CLOSE ( ) 414.50
OPEN PRICE ( ) 417.80
BID PRICE (QTY) 427.70 (373)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 330096
TODAY'S LOW / HIGH ( )409.00 429.90
52 WK LOW / HIGH ( )350.4 678.8
NSE427.8013.25 (+3.2 %)
PREV CLOSE( ) 414.55
OPEN PRICE ( ) 415.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 427.80 (3387)
VOLUME 5479802
TODAY'S LOW / HIGH( ) 408.90 429.95
52 WK LOW / HIGH ( )344.55 679.3
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
17Aug Sun Pharma, CMS ink licensing agreemen
Sun Pharmaceutical Industries’ one of wholly owned subsidiaries has gran..
14Aug CONCOR, Infosys and Wipro to see some
Container Corporation of India (CONCOR) and Indian Railways have joined..
14Aug Sun Pharma enters into licensing agree
Sun Pharmaceutical Industries has entered into a global licensing agreem..
13Aug Sun Pharma reports 31% rise in Q1 cons
Sun Pharmaceutical Industries has reported results for first quarter end..
03Aug Sun Pharma discontinues operations at
Sun Pharmaceutical Industries is discontinuing operations at two clinica..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit7633.78166
Gross Profit 7681.4 7194.5
Operating Profit 9609.730277
Net Sales 33090.1103032.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
peergroup  6032.65 (1.46%)
M.Cap ( in Cr)13893.57
Astrazeneca Pharma I (BSE)
peergroup  1746.40 (4.12%)
M.Cap ( in Cr)4366.00
Piramal Enterprises (BSE)
peergroup  1781.40 (3.23%)
M.Cap ( in Cr)35422.53
Abbott India (BSE)
peergroup  8786.90 (0.61%)
M.Cap ( in Cr)18671.55
Alkem Laboratories (BSE)
peergroup  1771.30 (1.21%)
M.Cap ( in Cr)21178.55
Shareholding Pattern
FI/BANKS/INSURANCE 7.67%
PROMOTERS 54.38%
NON-INSTITUTION 12.71%
MUTUAL FUNDS/UTI 10.26%
GOVERNMENT 0%
FII 0%
About Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. was incorporated in the year 01-03-1993. Its today's share price is 427.7. Its current market capitalisation stands at Rs 102619.56 Cr. In the latest quarter, company has reported Gross Sales of Rs. 563374.4 Cr and Total Income of Rs.301253.5 Cr. The company's management includes Sunil R Ajmera, Gautam Doshi, Vivek Chaand Sehgal, Rekha Sethi, Kalyanasundaram Subramanian, Sailesh T Desai, Sudhir V Valia, Dilip S Shanghvi, Israel Makov.

It is listed on the BSE with a BSE Code of 524715 , NSE with an NSE Symbol of SUNPHARMA and ISIN of INE044A01036. It's Registered office is at Sun Pharma Advanced Research Centre (S P A R C),Tandalja,Vadodara-390020, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells, Price Waterhouse, SRBC & Co LLP

Directory

current IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room